Non-Viral TCR Gene Therapy

首次发布于 2019 年 9 月 25 日

Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis

计划入组 3 人 · 首次发布于 2020 年 9 月 23 日

Gene Editing For Sickle Cell Disease

计划入组 25 人 · 首次发布于 2024 年 7 月 17 日

TTR gene editing therapy (Trucode Gene)

CYBB gene editing therapy (Trucode Gene)

FVIII gene therapy (Poseida Therapeutics/Takeda)

Frantz Viral Therapeutics, LLC

United States

VIETNAM VIRAL HEPATITIS ALLIANCE

United States

Advanced Viral Research Corp

The Bahamas

CellFE and Made Scientific Partner to Advance Non-Viral Gene Editing for T Cell Therapies

MaxCyte Partners with Anocca to Advance TCR-T Cell Therapy Manufacturing Using Non-Viral Gene Editing Platform

Cellectis Advances Gene Editing with Non-Viral TALEN Technology and TALE Base Editors at ASGCT 2025